. 2019 Nov 26;22:100708. doi: 10.1016/j.bbrep.2019.100708

Table 3.

Correlation between different parameters for patients group (n = 60).

		Tumor Size	Grade	Stage	Carcinoma in situ	Multicentric
Age (years)	r	-0.211	-0.334	-0.173	-0.096	-0.147
Age (years)	P	0.263	0.071	0.360	0.615	0.439
Affected lymph node	r	0.302	-0.083	0.236	-0.033	-0.042
Affected lymph node	P	0.105	0.664	0.209	0.861	0.824
Molecular type	r	0.236	0.465*	0.000	0.136	0.000
Molecular type	P	0.209	0.010*	1.000	0.472	1.000
Hb (g/dl)	r	-0.262	0.169	-0.436*	-0.035	0.440*
Hb (g/dl)	P	0.163	0.372	0.016*	0.854	0.015*
WBCs ( × 10³/μl)	r	-0.245	-0.545*	-0.497*	0.085	-0.278
WBCs ( × 10³/μl)	P	0.193	0.002*	0.005*	0.657	0.137
Platelets ( × 10³/μl)	r	0.061	0.084	0.018	0.104	-0.042
Platelets ( × 10³/μl)	P	0.748	0.660	0.925	0.585	0.824
CA 15–3 (IU/ml)	r	0.279	-0.032	0.109	-0.391*	-0.003
CA 15–3 (IU/ml)	P	0.135	0.866	0.565	0.032*	0.988

r: Pearson coefficient, *: Statistically significant at p ≤ 0.05, molecular type (1:luminal,2:Triple negative,3:Her2 Positive).